Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Active, not recruiting · NCT07193615 · Registry updated 2025-09-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD) | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Subcutaneous Emphysema, alpha 1-antitrypsin deficiency, hereditary disease, liver disorder, lung disorder, pulmonary emphysema, respiratory system disorder | Active, not recruiting | Early phase 1 | 2025-09-26 | NCT07193615 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| RenJi Hospital | 264 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ren Ji Hospital Affiliated to Shanghai Jiao Tong University | Shanghai | China | 1 |